Antengene unveils three pipeline programs at AACR 2026 as AnTenGager platform expands beyond UCB deal
Can Kailera become the next major GLP-1 challenger after pricing one of biotech’s biggest IPOs in years?
Read More Healthcare Industry News TransMedics revenue outlook lowers as leadership shifts focus Shares of TransMedics Group, Inc. dropped sharply, falling 8% to $77.92 during after-hours trading on Monday. The decline… byPallavi MadhirajuDecember 3, 2024